Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves in shares of Depomed, Inc. (NASDAQ: DEPO), NPS Pharmaceuicals (NASDAQ: NPSP), Mattson Technology, Inc. (NASDAQ: MTSN), and Xenoport, Inc. (NASDAQ: XNPT).
Depomed, Inc. (NASDAQ: DEPO) is down 30% premarket to $8.10, relative to a 52-week range of $2.32-$7.35. The FDA had just approved treatment of the pharma company’s neuralgia treatment.
NPS Pharmaceuicals (NASDAQ: NPSP) is up 25% this morning to $9.58, well above a 52-week range of $3.10-$8.30. The company had recently reported successful phase III trials of a short bowel system treatment.
Mattson Technology, Inc. (NASDAQ: MTSN) is down 5% premarket to $2.20, relative to a 52-week range of $1.93-$5.52.
Xenoport, Inc. (NASDAQ: XNPT) is up 8.3% to $8.45, relative to a 52-week range of $5.66-$20.48.
